pazufloxacin has been researched along with Urinary Tract Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuoka, Y; Ikeda, Y; Narita, H; Takahata, M; Todo, Y; Yamashiro, Y | 1 |
| Andoh, S; Horiba, Y; Ishikawa, K; Katoh, S; Naide, Y; Suzuki, K; Yanaoka, L | 1 |
1 trial(s) available for pazufloxacin and Urinary Tract Infections
| Article | Year |
|---|---|
Laboratory and clinical study of T-3761, a new fluoroquinolone, in urinary tract infection.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Oxazines; Prostate; Pseudomonas aeruginosa; Urinary Tract Infections | 1995 |
1 other study(ies) available for pazufloxacin and Urinary Tract Infections
| Article | Year |
|---|---|
In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Lung Diseases; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Urinary Tract Infections | 1993 |